We are live on ! Find out more
BIOA

BioAge Labs
BIOA

65 hedge funds and large institutions have $114M invested in BioAge Labs in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 29

12% more funds holding

Funds holding: 58 → 65 (+7)

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

29% less funds holding in top 10

Funds holding in top 10: 7 → 5 (-2)

74% less capital invested

Capital invested by funds: $431M → $114M (-$317M)

1,149.26% less ownership

Funds ownership: 1,204.05% → 54.79% (-1,149%)

Holders
65
Holders Change
+7
Holders Change %
+12.07%
% of All Funds
0.86%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.07%
New
36
Increased
11
Reduced
11
Closed
29
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$22.7M
2
CAM
Cormorant Asset Management
Massachusetts
+$17.2M
3
BlackRock
BlackRock
New York
+$12.3M
4
Morgan Stanley
Morgan Stanley
New York
+$7.6M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.46M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$20.7M
2
RCM
RA Capital Management
Massachusetts
-$15.5M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$9.36M
4
O
OrbiMed
New York
-$8.65M
5
Brown Advisory
Brown Advisory
Maryland
-$6.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$440K +$1.31M +75,908 New
State Street
27
State Street
Massachusetts
$274K +$817K +47,409 New
SCM
28
Silverarc Capital Management
Massachusetts
$231K -$1.04M -60,026 -60%
MA
29
MYDA Advisors
New York
$174K +$517K +30,000 New
Norges Bank
30
Norges Bank
Norway
$161K -$210K -12,171 -30%
EGM
31
Engineers Gate Manager
New York
$141K +$421K +24,416 New
Bank of America
32
Bank of America
North Carolina
$115K +$333K +19,294 +3,675%
PCM
33
Prelude Capital Management
New York
$115K +$341K +19,800 New
Barclays
34
Barclays
United Kingdom
$109K +$119K +6,891 +58%
Skandinaviska Enskilda Banken (SEB)
35
Skandinaviska Enskilda Banken (SEB)
Sweden
$108K +$329K +19,074 New
N
36
Nuveen
North Carolina
$89.4K +$266K +15,448 New
Millennium Management
37
Millennium Management
New York
$86.6K -$2.6M -151,057 -91%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$85K +$253K +14,685 New
VM
39
Valor Management
Illinois
$75.9K – – –
Squarepoint
40
Squarepoint
New York
$71K -$415K -24,051 -66%
GCP
41
GSA Capital Partners
United Kingdom
$70K +$209K +12,146 New
WIA
42
Wealthedge Investment Advisors
New York
$61.3K +$183K +10,585 New
VF
43
Virtu Financial
New York
$59K +$175K +10,132 New
SG Americas Securities
44
SG Americas Securities
New York
$59K +$175K +10,174 New
Citigroup
45
Citigroup
New York
$55.3K +$165K +9,555 New
Mirae Asset Global ETFs Holdings
46
Mirae Asset Global ETFs Holdings
Hong Kong
$38.6K +$115K +6,667 New
Wells Fargo
47
Wells Fargo
California
$36.5K +$109K +6,302 New
CF
48
Corebridge Financial
Texas
$34.9K +$104K +6,032 New
JP Morgan Chase
49
JP Morgan Chase
New York
$30.9K -$3.36M -194,665 -97%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$22.3K +$66.5K +3,858 New
1
2
3 4

BIOA Hedge Fund Activity: Q4 2024 in Review

65 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q4 2024, worth a combined $114M — down 74% from $431M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new BIOA positions and 29 closed out — a net gain of 7 holders — while 11 added to existing stakes and 11 trimmed.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $22.7M. The largest seller was AllianceBernstein, exiting entirely with an estimated $20.7M sold.

  • 65 institutional investors held BioAge Labs (BIOA) as of Q4 2024, up from 58 in Q3 2024.
  • Funds reported $114M of BioAge Labs stock for Q4 2024, down 74% quarter-over-quarter.
  • 36 funds opened new BioAge Labs positions in Q4 2024 and 29 closed out, a net change of +7 holders.
  • The largest BioAge Labs buyer in Q4 2024 was Tang Capital Management, an estimated $22.7M added.
  • The largest BioAge Labs seller in Q4 2024 was AllianceBernstein, an estimated $20.7M sold.

Based on aggregated 13F filings for Q4 2024.